BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30036891)

  • 1. The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis.
    Tóth B; Hegyi P; Lantos T; Szakács Z; Kerémi B; Varga G; Tenk J; Pétervári E; Balaskó M; Rumbus Z; Rakonczay Z; Bálint ER; Kiss T; Csupor D
    Planta Med; 2019 Jan; 85(1):24-31. PubMed ID: 30036891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action.
    Lopresti AL; Drummond PD
    Hum Psychopharmacol; 2014 Nov; 29(6):517-27. PubMed ID: 25384672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials.
    Ghaderi A; Asbaghi O; Reiner Ž; Kolahdooz F; Amirani E; Mirzaei H; Banafshe HR; Maleki Dana P; Asemi Z
    Complement Ther Med; 2020 Jan; 48():102250. PubMed ID: 31987241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saffron, as an adjunct therapy, contributes to relieve depression symptoms: An umbrella meta-analysis.
    Musazadeh V; Zarezadeh M; Faghfouri AH; Keramati M; Ghoreishi Z; Farnam A
    Pharmacol Res; 2022 Jan; 175():105963. PubMed ID: 34757208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.
    Hausenblas HA; Heekin K; Mutchie HL; Anton S
    J Integr Med; 2015 Jul; 13(4):231-40. PubMed ID: 26165367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis.
    Dai L; Chen L; Wang W
    J Nerv Ment Dis; 2020 Apr; 208(4):269-276. PubMed ID: 32221179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms.
    Han S; Cao Y; Wu X; Xu J; Nie Z; Qiu Y
    Phytother Res; 2024 May; 38(5):2276-2302. PubMed ID: 38424688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
    Hausenblas HA; Saha D; Dubyak PJ; Anton SD
    J Integr Med; 2013 Nov; 11(6):377-83. PubMed ID: 24299602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review.
    Dwyer AV; Whitten DL; Hawrelak JA
    Altern Med Rev; 2011 Mar; 16(1):40-9. PubMed ID: 21438645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression.
    Tabeshpour J; Sobhani F; Sadjadi SA; Hosseinzadeh H; Mohajeri SA; Rajabi O; Taherzadeh Z; Eslami S
    Phytomedicine; 2017 Dec; 36():145-152. PubMed ID: 29157808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression.
    Mazidi M; Shemshian M; Mousavi SH; Norouzy A; Kermani T; Moghiman T; Sadeghi A; Mokhber N; Ghayour-Mobarhan M; Ferns GA
    J Complement Integr Med; 2016 Jun; 13(2):195-9. PubMed ID: 27101556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary therapies for clinical depression: an overview of systematic reviews.
    Haller H; Anheyer D; Cramer H; Dobos G
    BMJ Open; 2019 Aug; 9(8):e028527. PubMed ID: 31383703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
    Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study.
    Lu C; Ke L; Li J; Zhao H; Lu T; Mentis AFA; Wang Y; Wang Z; Polissiou MG; Tang L; Tang H; Yang K
    Phytomedicine; 2021 Oct; 91():153699. PubMed ID: 34419735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].
    Akhondzadeh S; Fallah-Pour H; Afkham K; Jamshidi AH; Khalighi-Cigaroudi F
    BMC Complement Altern Med; 2004 Sep; 4():12. PubMed ID: 15341662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. affron
    Lopresti AL; Drummond PD; Inarejos-García AM; Prodanov M
    J Affect Disord; 2018 May; 232():349-357. PubMed ID: 29510352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
    Shahmansouri N; Farokhnia M; Abbasi SH; Kassaian SE; Noorbala Tafti AA; Gougol A; Yekehtaz H; Forghani S; Mahmoodian M; Saroukhani S; Arjmandi-Beglar A; Akhondzadeh S
    J Affect Disord; 2014 Feb; 155():216-22. PubMed ID: 24289892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.
    Akhondzadeh S; Sabet MS; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SSh; Yousefi MH; Alimardani R; Jamshidi A; Zare F; Moradi A
    J Clin Pharm Ther; 2010 Oct; 35(5):581-8. PubMed ID: 20831681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Crocus sativus L. (saffron) and crocin in the treatment of patients with type-2 diabetes mellitus: A systematic review and meta-analysis.
    Amatto PPG; Chaves L; Braga GG; Carmona F; Pereira AMS
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117255. PubMed ID: 37778521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
    Lopresti AL; Drummond PD
    J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.